Status
Conditions
Treatments
About
PRODIPET Study Summary
Title: Multicenter Registry for Chest Wall Reconstruction Using Custom 3D-Printed Titanium Prostheses
Purpose
The PRODIPET study evaluates the safety and effectiveness of personalized, dynamic titanium prostheses for reconstructing the chest wall after:
Tumor resection (e.g., sarcomas, lung cancer). Severe trauma (e.g., multiple rib fractures). Traditional methods (metal plates, mesh) often lack flexibility, potentially causing pain or breathing difficulties. This study tests 3D-printed titanium implants designed to mimic natural rib movement, improving function and comfort.
Study Design
Type: Multicenter, ambispective (retrospective + prospective data).
Duration:
Prospective: 24 months (Jan 2024-Jan 2026). Follow-up: 12 months per patient (final analysis by 2027). Centers: Major Spanish hospitals (Ramón y Cajal/Madrid, La Ribera/Alzira, Cruces/Baracaldo, Insular/Las Palmas).
Key Goals
Assess short/mid-term outcomes (pain, breathing, complications). Compare results across patients/surgical techniques. Improve future prosthesis designs. Who Can Participate?
Inclusion:
Adults (18+) needing chest wall reconstruction. Signed consent for anonymized data sharing.
Exclusion:
Titanium allergies. Participation in conflicting studies. Patient Experience
Pre-Surgery:
CT scan creates a custom 3D prosthesis (made by Osteobionix® using Ti6AL4V-ELI titanium).
Surgery:
Surgeons implant the prosthesis, anchoring it to ribs/sternum.
Follow-Up:
Evaluations at discharge, 1/6/12 months (in-person or phone). Measures: Pain, lung function, imaging (X-ray/CT), complications (e.g., infection, implant failure).
Privacy & Ethics
Data is anonymized and stored securely (REDCap system). Complies with European General Data Protection Regulation (EU GDPR) and Spanish data protection laws.
Patients may withdraw anytime. For Healthcare Providers
Collaboration: Open to thoracic surgeons/researchers. Data Access: Centralized via REDCap; analyzed by the coordinating team. Publications: Multicenter results will be published first; individual centers may later share their data.
Why This Matters
Addresses a gap in evidence for dynamic prostheses, which may offer:
Better breathing mechanics vs. rigid materials. Fewer long-term complications (e.g., breakage). Could standardize best practices for complex reconstructions. Contact
Lead Coordinator: Dr. Nicolás Moreno Mata (Hospital Ramón y Cajal, Madrid). Email: nicolas.moreno.hrc@gmail.com | Phone: +34 647 609 363.
Key Takeaways:
Patients/Families: Learn if custom prostheses improve recovery. Providers: Contribute to advancing surgical options. Researchers: Access multicenter data on innovative implants.
Full description
Here's a detailed yet accessible description of the PRODIPET study:
**PRODIPET Study: A Comprehensive Multicenter Investigation into 3D-Printed Titanium Chest Wall Reconstruction**
**Background and Rationale** Chest wall defects resulting from tumor resections or traumatic injuries present significant surgical challenges. Traditional reconstruction methods using rigid materials like methylmethacrylate or steel plates often compromise respiratory mechanics and patient comfort. The PRODIPET study examines an innovative solution: patient-specific, 3D-printed titanium prostheses designed to replicate natural chest wall dynamics.
**Study Design and Methodology**
This national multicenter registry combines:
**Technical Innovation**
The prostheses are:
Custom-designed using preoperative CT scans
Manufactured via electron beam melting of Ti6AL4V-ELI titanium powder
Engineered to provide:
**Clinical Protocol**
Preoperative Phase:
Surgical Phase:
Postoperative Follow-up:
Standardized evaluations at:
Assessments include:
**Data Collection and Management**
Secure REDCap database hosted by EJIE (Informatic Society of Basque Government, IT)
Comprehensive variables tracked:
**Participant Protection**
CEIm (ethical committee)-approved protocol (Hospital Ramón y Cajal Ethics Committee)
GDPR-compliant data handling
Two-tier identification system:
Right to withdraw without penalty
**Scientific Objectives**
Primary:
Secondary:
**Clinical Significance**
This study addresses critical gaps in thoracic reconstruction by:
**Collaborative Structure**
**Dissemination Plan**
Interim analysis at 12 months
Final results publication anticipated 2027
Data sharing policy:
This rigorous, patient-focused investigation represents a significant advancement in thoracic surgical care, combining cutting-edge engineering with clinical expertise to improve outcomes for patients with complex chest wall defects.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Patients must meet ALL of the following:
• Age: ≥18 years
Clinical Indication:
Patients will be excluded if ANY of the following apply:
Primary purpose
Allocation
Interventional model
Masking
60 participants in 1 patient group
Loading...
Central trial contact
Nicolás Moreno Mata MD, PhD, Medicine
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal